Trivascular Technologies, Inc. IPO Research Information

Trivascular Technologies, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Trivascular Technologies, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Trivascular Technologies, Inc.	TRIV - NASDAQ	$13.00-$15.00	$12.00	$11.35	6.5 million	4/16/2014
Underwriter(s): J.P. Morgan, Credit Suisse
Co-Manager(s): Canaccord Genuity, Stifel
Industry: Health Care
Filing(s): Filed 2014-03-10 Terms Added 2014-04-03

Trivascular Technologies, Inc. Quote & Chart - Click for current quote - TRIV

About Trivascular Technologies, Inc. (adapted from Trivascular Technologies, Inc. prospectus):
They are a medical device company developing and commercializing innovative technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms, or AAA.

This description is adapted from Trivascular TRIV prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Trivascular TRIV "TRIV" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.